onco360

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for GOMEKLI (mirdametinib), Manufactured By SpringWorks Therapeutics

LOUISVILLE, Ky., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…

2 months ago

BrightSpring Health Services Announces Onco360 Has Been Selected as a Partner for Several New Drugs

LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud…

5 months ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a…

5 months ago